Effect of Mycobacterium w on IL-6 and Oxygen Requirement in COVID-19

Shailaja Behera1, Mukesh K Gupta1, Hardik Dudhatra2

  • 1Consultant; Apex Super Specialty Hospital & Postgraduate Institute, Varanasi, Uttar Pradesh, India.

Insights

Heat-killed Mycobacterium w (Mw) shows promise for severe COVID-19. This treatment improved oxygen saturation and IL-6 levels, with 80% of patients discharged after successful oxygen weaning.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Pulmonology

Background:

  • Severe COVID-19 presents significant challenges, often requiring intensive care.
  • Comorbidities complicate COVID-19 management and patient outcomes.
  • Exploring novel therapeutic agents is crucial for improving severe COVID-19 treatment.

Purpose of the Study:

  • To evaluate the efficacy and safety of heat-killed Mycobacterium w (Mw) in patients with severe COVID-19.
  • To assess the impact of Mw treatment on key clinical and laboratory parameters.

Main Methods:

  • A study involving 25 hospitalized patients with severe COVID-19 and comorbidities.
  • Intradermal injection of 0.3 mL of heat-killed Mycobacterium w (Mw) daily for three consecutive days.
  • Comparison of clinical and laboratory markers (leukocyte and platelet counts, CRP, IL-6, liver enzymes, oxygen saturation) before and after Mw treatment.

Main Results:

  • Significant improvements observed in interleukin-6 (IL-6) levels and oxygen saturation (p < 0.001).
  • Marked enhancements in platelet count, C-reactive protein (CRP) levels, liver enzymes, and clinical response scores.
  • Eighty percent of patients on oxygen support were weaned to room air within 5.6 days, leading to discharge.

Conclusions:

  • Heat-killed Mycobacterium w (Mw) demonstrates potential as a safe and effective therapeutic option for severe COVID-19.
  • Mw treatment may contribute to faster recovery and reduced hospital stay in severe COVID-19 patients.
  • Further research into Mw as a COVID-19 therapeutic modality is warranted.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
321
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
533
Oxygen Requirements and Growth Patterns01:29

Oxygen Requirements and Growth Patterns

Microorganisms exhibit diverse oxygen requirements and growth patterns driven by their metabolic strategies and environmental adaptations. Oxygen, while essential for many organisms, can also be toxic under certain conditions, shaping how microorganisms grow and survive.Oxygen Requirements of MicroorganismsMicroorganisms are classified based on their ability to use or tolerate oxygen:● Obligate aerobes like Mycobacterium tuberculosis need oxygen for energy production, as it serves as the...
231
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
438
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.0K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
512